Last reviewed · How we verify

NCT06303388

Effects of Bruegger's Exercises Versus Egoscue Exercise on Lower Cross Syndrome

Status unknown NA Last updated 12 March 2024
What this trial tests

NA trial testing Bruegger,s Exercise in Lower Cross Syndrome in 34 participants. Status unknown.

Timeline
26 February 2024
Primary endpoint
30 May 2024
15 June 2024

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment34
Start date26 February 2024
Primary completion30 May 2024
Estimated completion15 June 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 16 to 65, any sex, with Lower Cross Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to find effects of Bruegger's Exercise versus Egoscue exercise on pain and hyperlordosis on patient with lower cross syndrome. This is interventional study which recruits 34 participants ,14 in each group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lower Cross Syndrome

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06303388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing